Bright Minds Biosciences (NASDAQ:DRUG) Issues Earnings Results, Beats Estimates By $0.28 EPS
Bright Minds Biosciences (NASDAQ:DRUG - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.70) earnings per share (EPS) for the quarter, beating analysts...